Gamma Investing LLC Crispr Therapeutics Ag Transaction History
Gamma Investing LLC
- $18.8 Billion
- Q1 2025
A detailed history of Gamma Investing LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Gamma Investing LLC holds 4,288 shares of CRSP stock, worth $166,417. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,288
Previous 52
8146.15%
Holding current value
$166,417
Previous $2.05 Million
93.84%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CRSP
# of Institutions
485Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$348 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$339 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$148 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$108 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$107 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.03B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....